MAB8256
Anti-Influenza A Antibody, H1N1 Antigen, clone 9B3.2
ascites fluid, clone 9B3.2, Chemicon®
Sign Into View Organizational & Contract Pricing
All Photos(1)
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Recommended Products
biological source
mouse
Quality Level
antibody form
ascites fluid
antibody product type
primary antibodies
clone
9B3.2, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunofluorescence: suitable
isotype
IgG2a
shipped in
wet ice
Specificity
Influenza A H1N1 antigen.
• Reacts strongly with all H1N1 strains tested including Beijing, A/ Texas /36/91, A/Berkeley/1/98, A/HongKong/503/97, A/Nanchang /16A/98,A/PR/8/34, New Caledonia strain, and A/California/7/2009.
• No reactivity shown to Influenza B strains.
• Reacts strongly with all H1N1 strains tested including Beijing, A/ Texas /36/91, A/Berkeley/1/98, A/HongKong/503/97, A/Nanchang /16A/98,A/PR/8/34, New Caledonia strain, and A/California/7/2009.
• No reactivity shown to Influenza B strains.
Immunogen
Epitope: H1N1 Antigen
Influenza blend
Application
Anti-Influenza A Antibody, H1N1 Antigen, clone 9B3.2 is an antibody against Influenza A for use in IF.
Indirect Immunofluorescence : 1/32
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
Physical form
Ascites
Storage and Stability
Maintain at -20°C. Avoid repeated freeze/thaw cycles.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
WGK
nwg
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Asami Makino et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 31(4), 1301-1322 (2016-08-06)
We identified a novel, nontoxic mushroom protein that specifically binds to a complex of sphingomyelin (SM), a major sphingolipid in mammalian cells, and cholesterol (Chol). The purified protein, termed nakanori, labeled cell surface domains in an SM- and Chol-dependent manner
Brian J Morrison et al.
Journal of virological methods, 248, 7-18 (2017-06-19)
This study describes an antibody-dependent NK cell degranulation assay, as a biomarker to assess antibody-dependent cellular cytotoxicity (ADCC) response in influenza plasma and for antibody therapies against influenza infection. The concentration of neutralizing antibodies (NAbs) against the hemagglutinin receptor of
Rapid typing, subtyping and RNA quantification of influenza virus type A strains in respiratory secretions.
Elena Percivalle,Francesca Rovida,Antonio Piralla,Vanina Rognoni,Maurizio Zavattoni et al.
The New Microbiologica null
Sreekumar Othumpangat et al.
Pathogens (Basel, Switzerland), 12(1) (2023-01-22)
Understanding the host response to influenza A virus (IAV) infection is vital for developing intervention strategies. The primary barriers for invading respiratory pathogens are the respiratory tract epithelial cells and antimicrobial proteins generated by these cells. The antimicrobial peptide, β-defensin-1
Amani Audi et al.
Frontiers in microbiology, 11, 612-612 (2020-05-20)
Influenza A virus (IAV) is a major human respiratory pathogen causing annual epidemics as well as periodic pandemics. A complete understanding of the virus pathogenesis and host factors involved in the viral lifecycle is crucial for developing novel therapeutic approaches.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service